Prospective evaluation of minimal residual disease in multiple myeloma following autologous stem cell transplantation(ASCT) and consolidation therapy.

被引：0
|
作者：
Patekar, Mukesh
Kumar, Lalit
Sharma, Atul
Gupta, Ritu
Vishnubhatla, Sreenivas
Naik, Ramavath Devendra
Pai, Rohit Ramesh
Tiwari, Akash
Dahiya, Meetu
机构：
[1] AIIMS, New Delhi, India
[2] All India Inst Med Sci, Dept Biostat, New Delhi, India
[3] All India Inst Med Sci, Dr BRA Inst Rotary Canc Hosp, New Delhi, India
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e20033
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20033
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Deferring autologous stem cell transplantation for consolidation of minimal residual disease in multiple myeloma
    Braunstein, Marc
    Niesvizky, Ruben
    SEMINARS IN ONCOLOGY, 2016, 43 (06) : 709 - 711
  • [2] Minimal residual disease evaluation in autologous stem cell transplantation recipients with multiple myeloma
    Gupta, Ritu
    Kumar, Lalit
    Dahiya, Meetu
    Mathur, Nitin
    Harish, P.
    Sharma, Atul
    Sharma, Om Dutt
    Shekhar, Varun
    LEUKEMIA & LYMPHOMA, 2017, 58 (05) : 1234 - 1237
  • [3] Minimal Residual Disease (MRD) ratio before and after Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma
    Boncompagni, Riccardo
    Staderini, Michela
    Nozzoli, Chiara
    Antonioli, Elisabetta
    Caporale, Roberto
    Peruzzi, Benedetta
    Cutini, Ilaria
    Gozzini, Antonella
    Serena, Mariotti
    Guidi, Stefano
    Jance, Blerina
    Accogli, Barbara
    Francesco, Annunziato
    Bosi, Alberto
    Saccardi, Riccardo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E172 - E172
  • [4] Peripheral Immune Profile and Minimal Residual Disease (MRD) Burden Following Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM)
    Foureau, David
    Zhang, Qing
    Cogdill, Tammy D.
    Wynn, Adina S.
    Steuerwald, Nury M.
    Druhan, Lawrence J.
    Guo, Fei
    Rigby, Katherine
    Madden, Kyle L.
    Symanowski, James T.
    Avalos, Belinda R.
    Copelan, Edward A.
    Usmani, Saad Z.
    Bhutani, Manisha
    BLOOD, 2016, 128 (22)
  • [5] Multiple myeloma: Maintenance therapy after autologous stem cell transplantation, depending on minimal residual disease
    Solovyev, M. V.
    Mendeleeva, L. P.
    Pokrovskaya, O. S.
    Nareyko, M. V.
    Firsova, M. V.
    Galtseva, I. V.
    Davydova, Yu. O.
    Kapranov, N. M.
    Kuzmina, L. A.
    Gemdzhian, E. G.
    Savchenko, V. G.
    TERAPEVTICHESKII ARKHIV, 2017, 89 (07) : 25 - 31
  • [6] Autologous stem cell transplantation (ASCT) followed by consolidation chemotherapy for multiple myeloma (MM).
    Gojo, I
    Murthy, A
    Fassas, A
    Tricot, G
    Fenton, R
    Mookerjee, B
    Meisenberg, B
    Takebe, N
    Frankel, SR
    Sarkodee-Adoo, C
    Heyman, MR
    Ruehle, K
    Smith, R
    Chen, T
    Rapoport, A
    BLOOD, 2000, 96 (11) : 369B - 369B
  • [7] Autologous stem cell transplantation (ASCT) followed by consolidation chemotherapy for multiple myeloma (MM).
    Murthy, A
    Gojo, I
    Fassas, A
    Tricot, G
    Fenton, R
    Mookerjee, B
    Meisenberg, B
    Takebe, N
    Lipani, T
    Badros, A
    Phillips, G
    Sarkodee-Adoo, C
    Heyman, M
    Ruehle, K
    Smith, R
    Guo, CF
    Rapoport, A
    BLOOD, 2001, 98 (11) : 685A - 685A
  • [8] MONITORING OF MINIMAL RESIDUAL DISEASE (MRD) IN PATIENTS WITH MULTIPLE MYELOMA (MM) BEFORE AND AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT)
    Galtseva, I.
    Mendeleeva, L.
    Pokrovskaya, O.
    Kastrikina, I.
    Urnova, E.
    Kuzmina, L.
    Parovichnikova, E.
    Savchenko, V.
    HAEMATOLOGICA, 2014, 99 : 647 - 647
  • [9] Autologous NK cells as consolidation therapy following stem cell transplantation in multiple myeloma
    Nahi, Hareth
    Chrobok, Michael
    Meinke, Stephan
    Gran, Charlotte
    Marquardt, Nicole
    Afram, Gabriel
    Sutlu, Tolga
    Gilljam, Mari
    Stellan, Birgitta
    Wagner, Arnika K.
    Blomberg, Pontus
    Holmqvist, Per-Henrik
    Walther-Jallow, Lilian
    Mellstrom, Karin
    Liwing, Johan
    Gustafsson, Charlotte
    Mansson, Robert
    Klimkowska, Monika
    Gahrton, Gosta
    Lund, Johan
    Ljungman, Per
    Ljunggren, Hans-Gustaf
    Alici, Evren
    CELL REPORTS MEDICINE, 2022, 3 (02)
  • [10] Minimal residual disease (MRD) ratio before and after autologous stem cells transplantation (ASCT) in multiple myeloma (MM)
    Boncompagni, Riccardo
    Staderini, Michela
    Nozzoli, Chiara
    Antonioli, Elisabetta
    Accogli, Barbara
    Saccardi, Riccardo
    BONE MARROW TRANSPLANTATION, 2019, 54 : 121 - 122
12345